128 related articles for article (PubMed ID: 16865255)
1. The morphology of perinecrotic tumor cell nuclei in glioblastomas shows a significant relationship with survival time.
Nafe R; Franz K; Schlote W; Schneider B
Oncol Rep; 2006 Sep; 16(3):555-62. PubMed ID: 16865255
[TBL] [Abstract][Full Text] [Related]
2. Morphology of tumor cell nuclei is significantly related with survival time of patients with glioblastomas.
Nafe R; Franz K; Schlote W; Schneider B
Clin Cancer Res; 2005 Mar; 11(6):2141-8. PubMed ID: 15788659
[TBL] [Abstract][Full Text] [Related]
3. Quantitative investigation of nuclear morphology in glioblastomas and its relation to survival time.
Nafe R; Franz K; Schlote W; Schneider B
Clin Neuropathol; 2003; 22(3):129-36. PubMed ID: 12809355
[TBL] [Abstract][Full Text] [Related]
4. [Glioblastomas: clinical study and search for prognostic factors].
Mineo JF; Quintin-Roue I; Lucas B; Buburusan V; Besson G
Neurochirurgie; 2002 Dec; 48(6):500-9. PubMed ID: 12595806
[TBL] [Abstract][Full Text] [Related]
5. EGFR gene amplification in glioblastomas. Is there a relationship with morphology of tumor cell nuclei and proliferative activity?
Nafe R; Glienke W; Schlote W; Schneider B
Anal Quant Cytol Histol; 2001 Apr; 23(2):135-43. PubMed ID: 11332080
[TBL] [Abstract][Full Text] [Related]
6. Survivin expression in intracranial ependymomas and its correlation with tumor cell proliferation and patient outcome.
Preusser M; Wolfsberger S; Czech T; Slavc I; Budka H; Hainfellner JA
Am J Clin Pathol; 2005 Oct; 124(4):543-9. PubMed ID: 16146813
[TBL] [Abstract][Full Text] [Related]
7. Distribution of nuclear size and internuclear distance are important criteria for grading astrocytomas.
Nafe R; Van de Nes J; Yan B; Schlote W
Clin Neuropathol; 2006; 25(1):48-56. PubMed ID: 16465775
[TBL] [Abstract][Full Text] [Related]
8. Correlation between preoperative magnetic resonance spectroscopic data on high grade gliomas and morphology of Ki-67-positive tumor cell nuclei.
Nafe R; Herminghaus S; Raab P; Wagner S; Pilatus U; Schlote W; Zanella F; Lanfermann H
Anal Quant Cytol Histol; 2003 Jun; 25(3):131-8. PubMed ID: 12882084
[TBL] [Abstract][Full Text] [Related]
9. Histomorphometry of tumour cell nuclei in astrocytomas using shape analysis, densitometry and topometric analysis.
Nafe R; Schlote W; Schneider B
Neuropathol Appl Neurobiol; 2005 Feb; 31(1):34-44. PubMed ID: 15634229
[TBL] [Abstract][Full Text] [Related]
10. Correlation of nuclear morphometry of breast cancer in histological sections with clinicopathological features and prognosis.
Abdalla F; Boder J; Markus R; Hashmi H; Buhmeida A; Collan Y
Anticancer Res; 2009 May; 29(5):1771-6. PubMed ID: 19443402
[TBL] [Abstract][Full Text] [Related]
11. Correlation of proliferating cell nuclear antigen assessment, histologic parameters and age with survival in patients with glioblastoma multiforme.
Karkavelas G; Mavropoulou S; Fountzilas G; Christoforidou V; Karavelis A; Foroglou G; Papadimitriou C
Anticancer Res; 1995; 15(2):531-6. PubMed ID: 7763035
[TBL] [Abstract][Full Text] [Related]
12. Inducible cyclooxygenase (COX-2) in glioblastoma--clinical and immunohistochemical (COX-2-VEGF) correlations.
Buccoliero AM; Caldarella A; Gheri CF; Taddei A; Paglierani M; Pepi M; Mennonna P; Taddei GL
Clin Neuropathol; 2006; 25(2):59-66. PubMed ID: 16550738
[TBL] [Abstract][Full Text] [Related]
13. Pitfalls in the assessment of MGMT expression and in its correlation with survival in diffuse astrocytomas: proposal of a feasible immunohistochemical approach.
Capper D; Mittelbronn M; Meyermann R; Schittenhelm J
Acta Neuropathol; 2008 Feb; 115(2):249-59. PubMed ID: 17965865
[TBL] [Abstract][Full Text] [Related]
14. Hypericin uptake: a prognostic marker for survival in high-grade glioma.
Ritz R; Müller M; Dietz K; Duffner F; Bornemann A; Roser F; Tatagiba M
J Clin Neurosci; 2008 Jul; 15(7):778-83. PubMed ID: 18394904
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical detection of proliferating cell nuclear antigen and Ki-67 in mast cell tumors from dogs.
Abadie JJ; Amardeilh MA; Delverdier ME
J Am Vet Med Assoc; 1999 Dec; 215(11):1629-34. PubMed ID: 14567425
[TBL] [Abstract][Full Text] [Related]
16. Comparative immunohistochemical analysis of aurora-A and aurora-B expression in human glioblastomas. Associations with proliferative activity and clinicopathological features.
Samaras V; Stamatelli A; Samaras E; Arnaoutoglou C; Arnaoutoglou M; Stergiou I; Konstantopoulou P; Varsos V; Karameris A; Barbatis C
Pathol Res Pract; 2009; 205(11):765-73. PubMed ID: 19616898
[TBL] [Abstract][Full Text] [Related]
17. Caveolin-1 expression is variably displayed in astroglial-derived tumors and absent in oligodendrogliomas: concrete premises for a new reliable diagnostic marker in gliomas.
Cassoni P; Senetta R; Castellano I; Ortolan E; Bosco M; Magnani I; Ducati A
Am J Surg Pathol; 2007 May; 31(5):760-9. PubMed ID: 17460461
[TBL] [Abstract][Full Text] [Related]
18. Phosphorylated Pak1 level in the cytoplasm correlates with shorter survival time in patients with glioblastoma.
Aoki H; Yokoyama T; Fujiwara K; Tari AM; Sawaya R; Suki D; Hess KR; Aldape KD; Kondo S; Kumar R; Kondo Y
Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6603-9. PubMed ID: 18006760
[TBL] [Abstract][Full Text] [Related]
19. Clinical tumor growth and comparison with proliferation markers in non-functioning (inactive) pituitary adenomas.
Saeger W; Lüdecke B; Lüdecke DK
Exp Clin Endocrinol Diabetes; 2008 Feb; 116(2):80-5. PubMed ID: 18072009
[TBL] [Abstract][Full Text] [Related]
20. Tumor size and karyometric variables in brain astrocytoma.
Kostic A; Mihailovic D; Veselinovic S; Tasic D; Stefanovic I; Novak V; Stojanovic N; Veselinovic D; Pavlovic S
J BUON; 2009; 14(3):473-7. PubMed ID: 19810141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
